OUR PARTNERS
REDEFINING DRUG DELIVERY
Anodyne is actively expanding its pipeline through both internal clinical development and strategic external partnerships to maximize the commercial potential of its cutting-edge drug delivery platform. We are committed to collaborating with partners interested in commercializing products utilizing Anodyne’s HeroPatch™ technology.
The HeroPatch offers substantial advantages for pharmaceutical partners looking to achieve:
Increased Patient Adherence
-
Transdermally deliver up to 30mg/patch
-
Optimized to deliver: mAbs, peptides and nucleic acid agents
-
Reduced side effects
-
Lower discontinuation rates
Expanded Market Share
-
Eliminate cold chain distribution, reducing the amount of plastic/patient by 20x and the supply chain cost by 10x
-
Scalable manufacturing process
-
Life cycle management
Enabling Formulation Technology
-
Solid-state stability to injectable therapies
-
Tunable shape/size/dosage to address specific needs
-
Potential for combination therapies in a single patch